EDIT-301

· Editas Medicine, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for EDIT-301, covering 2025-01-31 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) [Phase 1, Phase 2]

See pricing